Cargando…
Therapeutic Targets of KRAS in Colorectal Cancer
SIMPLE SUMMARY: Colorectal cancer is among the most common cancers in the United States. The advancement in treatment and early diagnosis have enabled a reduction in mortality from the disease among the patients with early and localized disease; however, the survival continues to be dismal in the me...
Autores principales: | Rahman, Shafia, Garrel, Shimon, Gerber, Michael, Maitra, Radhashree, Goel, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699097/ https://www.ncbi.nlm.nih.gov/pubmed/34944853 http://dx.doi.org/10.3390/cancers13246233 |
Ejemplares similares
-
Protein Arginine Methyltransferase 5 as a Therapeutic Target for KRAS Mutated Colorectal Cancer
por: Shifteh, David, et al.
Publicado: (2020) -
Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
por: Saperstein, Rafael, et al.
Publicado: (2023) -
Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
por: Maitra, Radhashree, et al.
Publicado: (2017) -
Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer
por: Fogel, Elisha J, et al.
Publicado: (2021) -
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer
por: Maitra, Radhashree, et al.
Publicado: (2019)